뉴스벤징가
Tiziana Life Sciences Says Imaging Results Show Neuroinflammation Reduction in Rare Neurodegenerative Condition
· 발표
기사 요약
Tiziana Life Sciences reports reduced brain inflammation in its third Phase 2 trial patient treated with intranasal foralumab for MSA.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…